Call Options

15 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$12.78 - $17.4 $1.44 Million - $1.96 Million
-112,500 Reduced 49.78%
113,500 $1.84 Million
Q1 2024

May 15, 2024

BUY
$10.67 - $14.43 $2.19 Million - $2.96 Million
204,900 Added 971.09%
226,000 $3.19 Million
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $171,331 - $224,293
21,100 New
21,100 $220,000
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $278,516 - $485,170
40,600 New
40,600 $328,000
Q2 2021

Aug 16, 2021

SELL
$9.9 - $11.56 $442,530 - $516,732
-44,700 Reduced 66.42%
22,600 $224,000
Q4 2020

Feb 16, 2021

BUY
$8.61 - $11.04 $34,440 - $44,160
4,000 Added 6.32%
67,300 $649,000
Q1 2020

May 15, 2020

BUY
$6.69 - $13.45 $423,477 - $851,385
63,300 New
63,300 $568,000
Q3 2019

Nov 14, 2019

SELL
$6.16 - $9.6 $322,168 - $502,080
-52,300 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$8.12 - $15.72 $1.17 Million - $2.27 Million
-144,300 Reduced 73.4%
52,300 $483,000
Q1 2019

May 15, 2019

BUY
$15.58 - $20.01 $370,804 - $476,238
23,800 Added 13.77%
196,600 $3.08 Million
Q4 2018

Feb 14, 2019

SELL
$14.59 - $23.84 $6.19 Million - $10.1 Million
-424,300 Reduced 71.06%
172,800 $2.67 Million
Q3 2018

Nov 14, 2018

BUY
$21.06 - $25.65 $1.19 Million - $1.45 Million
56,500 Added 10.45%
597,100 $12.9 Million
Q2 2018

Aug 14, 2018

SELL
$16.77 - $24.71 $3.45 Million - $5.09 Million
-205,900 Reduced 27.58%
540,600 $13.1 Million
Q1 2018

May 15, 2018

BUY
$16.68 - $22.07 $11.7 Million - $15.5 Million
700,600 Added 1526.36%
746,500 $12.8 Million
Q4 2017

Feb 14, 2018

BUY
$11.23 - $19.1 $515,457 - $876,690
45,900
45,900 $870,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.